CD19 and neoplasm: CD19+ TAMs exhibit immunosuppressive functions by upregulating PD-L1 and CD73, thereby inhibiting T cell activity, and direct targeting with anti-CD19 CAR-T cells has been shown to suppress tumor growth (59).